Tag: European Medicines Agency
European Medicines Agency on AstraZeneca coronavirus vaccine: “benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets”
EMA Statement: “the vaccine may be associated with very rare cases of blood clots associated with thrombocytopenia, i.e.… ...More...
European Medicines Agency: Carry On Poisoning
EMA: “the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects.”… ...More...